|
|
Daniel P. Ankeny, Zhen Guan, Phillip G. Popovich
J Clin Invest. 2009;
119(10):2990
doi:10.1172/JCI39780
Abstract |
Full text
| PDF
| Supplemental material

T
raumatic injury to the mammalian spinal cord activates B cells, which culminates in the synthesis of autoantibodies. The functional significance of this immune response is unclear. Here, we show that locomotor recovery was improved and lesion pathology was reduced after spinal cord injury (SCI) in mice lacking B cells. After SCI, antibody-secreting B cells and Igs were present in the cerebrospinal fluid and/or injured spinal cord of WT mice but not mice lacking B cells. In mice with normal B cell function, large deposits of antibody and complement component 1q (C1q) accumulated at sites of axon pathology and demyelination. Antibodies produced after SCI caused pathology, in part by activating intraspinal complement and cells bearing Fc receptors. These data indicate that B cells, through the production of antibodies, affect pathology in SCI. One or more components of this pathologic immune response could be considered as novel therapeutic targets for minimizing tissue injury and/or promoting repair after SCI.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(13)
| Title and authors |
Publication |
Year |
ANALGESIA OR ADDICTION: IMPLICATIONS FOR MORPHINE USE AFTER SPINAL CORD INJURY
Sarah Ann Woller, Georgina L Moreno, Nigel Hart, Paul J Wellman, James W Grau, Michelle A Hook
|
Journal of Neurotrauma
|
2012 |
Challenging the role of adaptive immunity in neurotrauma: Rag1-/- mice lacking mature B and T cells do not show neuroprotection after closed head injury
Sebastian Weckbach, Miriam Neher, Justin Losacco, Ashley Bolden, Liudmila Kulik, Michael Flierl, Scott Bell, V Michael Holers, Philip Stahel
|
Journal of Neurotrauma
|
2012 |
Distinct roles for ERK1 and ERK2 in pathophysiology of CNS
Chen Guang Yu
|
Front. Biol.
|
2012 |
Anti-Inflammatory Treatments during the Chronic Phase of Spinal Cord Injury Improve Locomotor Function in Adult Mice
Sheila A. Arnold, Theo Hagg
|
Journal of Neurotrauma
|
2011 |
The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice
Akshata Almad, A. Todd Lash, Ping Wei, Amy E. Lovett-Racke, Dana M. McTigue
|
Experimental Neurology
|
2011 |
Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis
Ruth Huizinga, Baukje J. van der Star, Markus Kipp, Rosa Jong, Wouter Gerritsen, Tim Clarner, Fabiola Puentes, Christine D. Dijkstra, Paul van der Valk, Sandra Amor
|
Glia
|
2011 |
The Alternative and Terminal Pathways of Complement Mediate Post-Traumatic Spinal Cord Inflammation and Injury
Fei Qiao, Carl Atkinson, Mark S. Kindy, Anandakumar Shunmugavel, B. Paul Morgan, Hongbin Song, Stephen Tomlinson
|
The American Journal of Pathology
|
2010 |
The Potential Role of B Cell-Targeted Therapies in Multiple Sclerosis
Aaron Boster, Daniel P. Ankeny, Michael K. Racke
|
Drugs
|
2010 |
Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment
K. D. Beck, H. X. Nguyen, M. D. Galvan, D. L. Salazar, T. M. Woodruff, A. J. Anderson
|
Brain
|
2010 |
B cells and autoantibodies: complex roles in CNS injury
Daniel P. Ankeny, Phillip G. Popovich
|
Trends in Immunology
|
2010 |
|